Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
John Breton, MCM
GSK
Disclosure(s): GSK: Employee, Stocks/Bonds (Public Company)
Poster(s):
(P-1101) A Comparative Analysis of Resistance Rates Among
Escherichia coli
and
Klebsiella pneumoniae
Isolates Collected from the Gepotidacin Uropathogen Global Surveillance Studies and Phase 3 Uncomplicated Urinary Tract Infection Clinical Studies
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
(P-1492) Patient Characteristics Associated with Extended-Spectrum Beta-Lactamase-Producing Uropathogens: Pooled Results from Two Phase 3 Clinical Trials of Gepotidacin for the Treatment of Uncomplicated Urinary Tract Infection
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
